Marginal keratitis: An uncommon form of topical dorzolamide allergy

American Journal of Ophthalmology

Volumn 130, Issue 1, 2000, Pages 120-122

  Taguri, Abdel H ^a   Khan, Mushtaq A ^a   Sanders, Roshini ^b  

^a Ophthalmology   (United Kingdom)

^b QUEEN MARGARET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; KERATITIS; PHOTOPHOBIA; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; CARBONIC ANHYDRASE INHIBITORS; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMAN; KERATITIS; OPHTHALMIC SOLUTIONS; SULFONAMIDES; THIOPHENES;

EID: 0033825972     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00478-5     Document Type: Article

References (3)

1. Adamsons I.A., Polis A., Ostrov C.S., Boyle J.E. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group. J Glaucoma. 7:1998;395-401.
2. Balfour J.A., Wilde M.I. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. Drugs Aging. 10:1997;384-403.
3. Stern G.A., Knapp A. Iatrogenic peripheral corneal disease. Int Ophthalmol Clin. 26:1986;77-89.